8 unknown. 8 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Unknown 8 |
| Phase 2 | 6 | Unknown 6 |
Follow Hydroxychloroquine: new trials by email Literature Review of Hydroxychloroquine trials Research Report on Hydroxychloroquine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer Hydroxychloroquine, Sacituzumab Govitecan, Trastuzumab Deruxtecan - Advanced Breast Cancer, Metastatic Breast Cancer | Phase 1 / Phase 2 | Unknown | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 120 | 2024-01-29 | 2024-03-25 |
| Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss Hydroxychloroquine - Recurrent Pregnancy Loss | Phase 1 | Unknown | Ain Shams University | 70 | 2022-03-01 | 2022-02-14 |
| Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19 Hydroxychloroquine, Indomethacin, Zithromax Oral Product - COVID-19 | Phase 1 / Phase 2 | Unknown | Perseverance Research Center, LLC | 80 | 2020-04-16 | 2020-07-01 |
| Dabrafenib/Trametinib/Hydroxychloroquine for Advanced Pretreated BRAF V600 Mutant Melanoma Dabrafenib, Trametinib, Hydroxychloroquine - Melanoma | Phase 1 / Phase 2 | Unknown | Universitair Ziekenhuis Brussel | 63 | 2018-01-23 | 2021-04-28 |
| The Influence of Plaquenil/Hydroxychloroquine (HCQ) on Insulin Secretion Hydroxychloroquine - Diabetes Type Two | Phase 1 / Phase 2 | Unknown | Hadassah Medical Organization | 40 | 2016-10-01 | 2016-09-21 |
| Clinical Trial to Assess Safety and Efficacy of Combination Therapy: Hydroxychloroquine, Pegylated Interferon Alpha-2a and Ribavirin in Chronic Hepatitis C Subjects Non-responders to the Standard of Care Therapy. Hydroxychloroquine (HCQ), Pegylated Interferon Alpha-2a (Peg-IFN alpha-2a) and Ribavirin - Chronic Hepatitis C | Phase 1 / Phase 2 | Unknown | Sheba Medical Center | 36 | 2011-01-01 | 2011-01-07 |
| Hydroxychloroquine for Discordant CD4 Responders on Highly Active Antiretroviral Therapy (HAART) Hydroxychloroquine - HIV Infection | Phase 1 | Unknown | St Stephens Aids Trust | 12 | 2010-10-01 | 2014-02-11 |
| Hydroxychloroquine and Gefitinib to Treat Lung Cancer Gefitinib, Hydroxychloroquine - Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Unknown | National University Hospital, Singapore | 71 | 2008-11-01 | 2013-12-10 |
Breast Neoplasms (1) · COVID-19 (1) · Carcinoma, Non-Small-Cell Lung (1) · HIV Infections (1) · Hepatitis C, Chronic (1) · Melanoma (1)
Ain Shams University (1) · Hadassah Medical Organization (1) · National University Hospital, Singapore (1) · Perseverance Research Center, LLC (1) · Sheba Medical Center (1) · St Stephens Aids Trust (1) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1) · Universitair Ziekenhuis Brussel (1)
Belgium (1) · China (1) · Singapore (1) · United Kingdom (1) · United States (1)
Bart Neyns, MD PhD (1) · Jianli J Zhao, doctorate (1) · Laura Waters, Dr (1) · Nicole C. Hank, PhD, MCR, MHSM (1) · Tan Min Chin, MD (1) · Teresa Gaither, NP (1)
PMID 10632428, PMID 19439078, PMID 21112094, PMID 21718553, PMID 21871597, PMID 22002012, PMID 23942472, PMID 24581729, PMID 24995856, PMID 25653897, PMID 25681385, PMID 26371706, PMID 27100512, PMID 9344498
2008 (1)